Aziyo Biologics Rebrands As Elutia To Reflect Strategic Focus On Drug Eluting Biomatrices; Company To Begin Trading Under New Ticker Symbol "ELUT"
Portfolio Pulse from Happy Mohamed
Aziyo Biologics, Inc. (NASDAQ:AZYO) has rebranded to Elutia Inc. to reflect its strategic focus on drug-eluting biomatrix technology. The company's stock will begin trading under the new ticker symbol 'ELUT' on September 7, 2023. Elutia is developing new products for the pacemaker and implantable defibrillator markets, and is expected to expand into neurostimulator markets. The company also serves the market with its SimpliDerm® Acellular Dermal Matrix, used in breast reconstruction following mastectomy.

September 06, 2023 | 8:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aziyo Biologics has rebranded to Elutia and will trade under the new ticker 'ELUT'. The rebranding reflects the company's focus on drug-eluting biomatrix technology, which could potentially drive growth.
The rebranding of Aziyo Biologics to Elutia and the shift in strategic focus could potentially attract new investors and drive growth. The company's development of new products and expansion into new markets could also positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100